bp retatrutide - “Triple G” Retatrutide: A Triple Agonist Shaping
Description
Apart from promoting weight reduction, semaglutide has been discovered to lower blood pressure in both diabetics and non-diabetics, likely due to its impact on weight loss and reduced insulin resistance

I found that my cholesterol went up to 200 when I gained the extra weight
The conflicting data regarding ulcerative colitis risk warrants caution for IBD patients until more data is available

What drugs cannot be taken with semaglutide
HCP Training Needs Consideration of the training and ongoing support for conducting group GLP-1 RA starts needs to be available for clinicians wishing to provide this service to support the organisation, provision, enablement and evaluation of group GLP-1 RA starts in diabetes care
